Most medicines spent nearly seven years on wait list for funding

More than four million New Zealanders are missing out on modern medicines languishing on what is effectively Pharmac's drug wish list, according to a new report commissioned by Medicines New Zealand; a group representing the pharmaceutical industry. It says 137 modern medicines that Pharmac would buy if it could afford to have spent an average of six and half years on the Options for Investment list. The report says 83% of those medicines are so called standard of care drugs in other countries; meaning they are the go to treatments. Medicines NZ CEO Graeme Jarvis spoke to Lisa Owen.

Checkpoint · RNZ